Fernando Alcaide Fernández de Vega

Assistant Professor of Microbiology

Professor Associat de Microbiologia

E-mail: falcaide@csub.scs.es

Phone: +3493 2607930

 

 


 

Research Interests

 

Current Projects

 

Selected Recent Publications

 
Comparative in vitro activities of linezolid, telithromycin, clarithromycin,levofloxacin, moxifloxacin, and four conventional antimycobacterial drugsagainst Mycobacterium kansasii.
Alcaide F, Calatayud L, Santin M, Martin R.
Antimicrob Agents Chemother. 2004 Dec;48(12):4562-5. 
 
Incidence and molecular typing of Mycobacterium kansasii in a defined
geographical area in Catalonia, Spain.
Santin M, Alcaide F, Benitez MA, Salazar A, Ardanuy C, Podzamczer D, Rufi G,Dorca J, Martin R, Gudiol F. 
Epidemiol Infect. 2004 Jun;132(3):425-32. 
 
Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome.
Blancas D, Santin M, Olmo M, Alcaide F, Carratala J, Gudiol F. 
Eur J Clin Microbiol Infect Dis. 2004 Mar;23(3):168-73. Epub 2004 Feb 25. 
 
4:  Santin M, Alcaide F. 
Mycobacterium kansasii disease among patients infected with human
immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy.
Int J Tuberc Lung Dis. 2003 Jul;7(7):673-7. 
 
In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer.
Alcaide F, Benitez MA, Carratala J, Gudiol F, Linares J, Martin R. 
Antimicrob Agents Chemother. 2001 Feb;45(2):624-6. 
 
High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients.
Marron A, Carratala J, Alcaide F, Fernandez-Sevilla A, Gudiol F. 
J Antimicrob Chemother. 2001 Jan;47(1):87-91. 
 
Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer.
M arron A, Carratala J, Gonzalez-Barca E, Fernandez-Sevilla A, Alcaide F, Gudiol F. 
Clin Infect Dis. 2000 Nov;31(5):1126-30. Epub 2000 Nov 6. 
 
Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA
AccuProbe.
Alcaide F, Benitez MA, Escriba JM, Martin R. 
J Clin Microbiol. 2000 Jan;38(1):398-401.